Alexandria Schurer

Phenotypic dissection of epithelial lineages and therapeutic manipulation of differentiation programs in human Adenoid Cystic Carcinomas (ACCs)

D. Sahoo, C. Moskaluk, R. Rabadán, 2022, bioRxiv.

Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia

C. Leslie, R. Rabadán, U. Steidl, 2021, Nature Cancer.

IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.

Michael G. Kharas, C. Leslie, S. Armstrong, 2019, Cell stem cell.

High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells.

Sun-Mi Park, L. Cantley, M. Kharas, 2020, Cell metabolism.

Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells.

Michael G. Kharas, Sun-Mi Park, M. Kharas, 2022, Cancer cell.

Inverse agonists of RAR/RXR signaling as lineage-specific anti-tumor agents against human Adenoid Cystic Carcinoma.

D. Sahoo, C. Moskaluk, Junfei Zhao, 2023, Journal of the National Cancer Institute.

Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells.

Sun-Mi Park, M. Kharas, Christina M. Woo, 2023, Cancer cell.

Crizotinib has Preclinical Efficacy in Philadelphia-negative Myeloproliferative Neoplasms.

B. Halmos, R. Okabe, K. Ames, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.